Ying Su Selected Research

4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acid

1/2019	3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
9/2008	Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.
5/2007	An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Su Research Topics

Disease

79	Neoplasms (Cancer) 10/2022 - 06/2006
13	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2007
12	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2007
11	Inflammation (Inflammations) 01/2022 - 10/2011
10	Infections 12/2022 - 10/2009
10	Nasopharyngeal Carcinoma 01/2022 - 11/2010
7	Type 2 Diabetes Mellitus (MODY) 07/2022 - 08/2008
6	Fibrosis (Cirrhosis) 07/2022 - 07/2006
6	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2012
6	Carcinogenesis 07/2017 - 05/2007
5	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 05/2009
5	Diabetic Nephropathies (Diabetic Nephropathy) 08/2022 - 08/2012
5	Wounds and Injuries (Trauma) 01/2021 - 10/2007
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 01/2021
4	Cognitive Dysfunction 06/2022 - 11/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2020
4	Squamous Cell Carcinoma of Head and Neck 01/2020 - 05/2012
4	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 05/2007
4	Diabetes Mellitus 08/2015 - 09/2011
3	Glaucoma 09/2022 - 03/2010
3	Insulin Resistance 07/2022 - 01/2009
3	COVID-19 04/2022 - 01/2020
3	Body Weight (Weight, Body) 01/2022 - 02/2011
3	Ischemic Stroke 01/2022 - 08/2020
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 01/2019
3	Disease Progression 08/2021 - 01/2021
3	Hypoxia (Hypoxemia) 01/2021 - 01/2018
3	Pathologic Processes 01/2021 - 10/2008
3	Pneumonia (Pneumonitis) 11/2020 - 11/2019
3	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 06/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2017
3	Leukemia 01/2018 - 05/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2015
3	Hyperglycemia 08/2015 - 08/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013 - 08/2007
2	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2022 - 02/2022
2	Obesity 01/2022 - 02/2011

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 08/2022 - 07/2007
13	Biological ProductsIBA 02/2022 - 06/2007
12	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
11	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2015
9	Pharmaceutical PreparationsIBA 01/2020 - 08/2010
8	CytokinesIBA 07/2022 - 04/2013
7	EnzymesIBA 01/2022 - 01/2010
6	Phosphotransferases (Kinase)IBA 01/2019 - 10/2008
5	Therapeutic UsesIBA 07/2022 - 06/2002
5	Messenger RNA (mRNA)IBA 01/2022 - 09/2008
5	LigandsIBA 12/2020 - 01/2015
5	Small Interfering RNA (siRNA)IBA 01/2020 - 03/2010
5	Retinoid X Receptor alphaIBA 01/2019 - 05/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 05/2020
4	RNA (Ribonucleic Acid)IBA 10/2022 - 06/2012
4	Protein Tyrosine PhosphatasesIBA 08/2022 - 05/2007
4	Transcription Factors (Transcription Factor)IBA 04/2022 - 01/2017
4	GlucocorticoidsIBA 02/2022 - 02/2009
4	ripretinibIBA 12/2021 - 01/2019
4	Long Noncoding RNAIBA 01/2021 - 02/2016
4	Caspase 3 (Caspase-3)IBA 09/2020 - 08/2007
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2019 - 05/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2013
4	Soybean Proteins (Soy Protein)IBA 01/2010 - 05/2007
3	Retinaldehyde (Retinal)IBA 08/2022 - 10/2008
3	SteroidsIBA 04/2022 - 10/2016
3	Competitive Endogenous RNAIBA 02/2022 - 02/2016
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
3	Methionine (L-Methionine)FDA Link 01/2022 - 10/2020
3	CholesterolIBA 01/2022 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 12/2021 - 10/2017
3	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 08/2008
3	ErbB Receptors (EGF Receptor)IBA 04/2020 - 01/2014
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 10/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 12/2006
3	Peptides (Polypeptides)IBA 01/2019 - 12/2012
3	4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA 01/2019 - 05/2007
3	K-80003IBA 01/2019 - 06/2010
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017 - 01/2013
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2016 - 05/2007
3	TensinsIBA 11/2016 - 05/2007
3	Retinoid X Receptors (Retinoid X Receptor)IBA 09/2015 - 01/2013
3	GenisteinIBA 01/2013 - 05/2007
3	IsoflavonesIBA 01/2013 - 06/2007
3	Insulin (Novolin)FDA Link 02/2011 - 04/2008
2	DNA-Activated Protein KinaseIBA 12/2022 - 02/2022
2	LuciferasesIBA 10/2022 - 01/2021
2	Circular RNAIBA 10/2022 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 07/2022 - 08/2010
2	curcumolIBA 06/2022 - 01/2022
2	Sirtuin 1IBA 06/2022 - 01/2022
2	Methionine AdenosyltransferaseIBA 01/2022 - 12/2020
2	HDL CholesterolIBA 01/2022 - 08/2008
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 11/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014

Therapy/Procedure

21	Therapeutics 04/2022 - 06/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2010
3	Artificial Respiration (Mechanical Ventilation) 03/2022 - 08/2020
3	Radiotherapy 11/2016 - 08/2012
2	Punctures 01/2022 - 07/2020